These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17985624)

  • 1. Silver fluorescent x-ray yield and its influence on the dose rate constant for nine low-energy brachytherapy source models.
    Nath R; Chen ZJ
    Med Phys; 2007 Oct; 34(10):3785-93. PubMed ID: 17985624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Med Phys; 2007 Apr; 34(4):1412-30. PubMed ID: 17500473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic output of 125I and 103Pd low dose rate brachytherapy sources.
    Usher-Moga J; Beach SM; DeWerd LA
    Med Phys; 2009 Jan; 36(1):270-8. PubMed ID: 19235395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of source-production revision on the dose-rate constant of 131Cs interstitial brachytherapy sources.
    Chen Z; Bongiorni P; Nath R
    Med Phys; 2010 Jul; 37(7):3607-10. PubMed ID: 20831068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Phys Med Biol; 2010 Oct; 55(20):6089-104. PubMed ID: 20871136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
    Khan S; Chen ZJ; Nath R
    Med Phys; 2008 Apr; 35(4):1403-6. PubMed ID: 18491535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ; Bongiorni P; Nath R
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source.
    Rivard MJ; Davis SD; DeWerd LA; Rusch TW; Axelrod S
    Med Phys; 2006 Nov; 33(11):4020-32. PubMed ID: 17153382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
    Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
    Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric characterization of an encapsulated interstitial brachytherapy source of 125I on a tungsten substrate.
    Nath R; Yue N
    Brachytherapy; 2002; 1(2):102-9. PubMed ID: 15062178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed.
    Nath R; Yue N
    Appl Radiat Isot; 2001 Dec; 55(6):813-21. PubMed ID: 11761105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
    Li Z
    Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.
    Williamson JF
    Med Phys; 2002 Apr; 29(4):509-21. PubMed ID: 11991122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical dosimetry of 125I seeds of a new design for interstitial implant.
    Ling CC; Yorke ED; Spiro IJ; Kubiatowicz D; Bennett D
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1747-52. PubMed ID: 6643164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from emitted electrons.
    Ballester F; Granero D; Pérez-Calatayud J; Melhus CS; Rivard MJ
    Med Phys; 2009 Sep; 36(9):4250-6. PubMed ID: 19810499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
    Chen Z; Bongiorni P; Nath R
    Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
    Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
    Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.